Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Cardiology
100%
ST Segment Elevation Myocardial Infarction
96%
Congestive Heart Failure
80%
Defibrillation
51%
Heart Surgery
48%
Percutaneous Aortic Valve Replacement
48%
Chronic Total Occlusion
48%
Primary Percutaneous Coronary Intervention
41%
Infarction
33%
Implantable Automatic Defibrillator
32%
Primary Health Care
27%
Disease Management
27%
Quality of Life
27%
Defibrillator
26%
Basic Life Support
24%
Percutaneous Coronary Intervention
24%
Reperfusion Therapy
24%
Cardiovascular System
24%
New York Heart Association Class
24%
Chronic Thromboembolic Pulmonary Hypertension
24%
Pulmonary Artery
24%
Blood Pressure
24%
Pressure Control
24%
Awareness
24%
Cluster Randomized Trial
24%
Contrast Medium
24%
Radiation Exposure
24%
Device Infection
24%
Medical Implant
24%
Infection
24%
Antiinfective Agent
24%
Symptomatic Treatment
24%
Diseases
24%
Internal Medicine
24%
Infectious Mononucleosis
24%
Ulcerative Esophagitis
24%
Stent Malapposition
24%
Major Adverse Cardiac Event
24%
Alternative Technique
24%
Optical Coherence Tomography
24%
Drug-Eluting Stent
24%
Acute Coronary Syndrome
24%
Cardio-Oncology
24%
Cytomegalovirus
24%
Right Ventricle
20%
Hazard Ratio
18%
Angioplasty
18%
Coronary Occlusion
16%
Lung Artery Pressure
12%
Valvular Heart Disease
12%
Reflux Esophagitis
12%
Antiviral Therapy
12%
Esophagitis
12%
Immune Deficiency
12%
Recanalization
11%
Blood Pressure Reduction
10%
Hospital Mortality
10%
Infection Prevention
10%
Out of Hospital Cardiac Arrest
9%
Cardiac Resynchronization Therapy
8%
Lead Fracture
8%
Revascularization
8%
Dose Area Product
8%
Intention-to-Treat Analysis
8%
Adenosine Triphosphate
8%
Adverse Event
8%
Clinical Trial
7%
Magnetic Resonance Imaging
7%
Anterior Myocardial Infarction
6%
Thrombus Aspiration
6%
Propensity Score Matching
6%
Abciximab
6%
Aortic Stenosis
6%
Resuscitation
6%
Hemodynamic
6%
Prospective Study
6%
Vascular Lesion
6%
Treatment Response
6%
False Positive Result
6%
Left Atrial Volume
5%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
96%
Congestive Heart Failure
81%
Infection
48%
Chronic Total Occlusion
48%
Infarction
33%
Prospective Study
28%
Out of Hospital Cardiac Arrest
24%
Antiinfective Agent
24%
Cluster Randomized Trial
24%
Chronic Thromboembolic Pulmonary Hypertension
24%
Major Adverse Cardiac Event
24%
Device Infection
24%
Acute Coronary Syndrome
24%
Adenosine Triphosphate
24%
Adverse Event
24%
Contrast Medium
24%
Radiation Exposure
24%
Cohort Study
24%
Endocrine Therapy
24%
Coronary Artery Occlusion
16%
Atrial Fibrillation
12%
Implant
12%
Diseases
12%
Hospital Mortality
10%
Beta Adrenergic Receptor Blocking Agent
9%
Cross-Sectional Study
8%
Brain Natriuretic Peptide
8%
Anterior Myocardial Infarction
6%
Abciximab
6%
Vascular Lesion
6%
Nursing and Health Professions
Percutaneous Coronary Intervention
34%
Diseases
27%
Implantable Cardioverter Defibrillator
24%
Hormonal Therapy
24%
Pressure Control
24%
Cohort Analysis
24%
Blood Pressure
24%
Primary Medical Care
24%
Transgender
24%
Vertigo
24%
Coronary Artery Disease
24%
Quality of Life
24%
Dizziness
24%
ST Segment Elevation Myocardial Infarction
24%
Optical Coherence Tomography
24%
Reperfusion
24%
Palliative Therapy
24%
Basic Life Support
24%
Congestive Heart Failure
24%
Automated External Defibrillator
18%
Heart Left Ventricle Ejection Fraction
12%
Predictive Value
12%
Hospital Mortality
10%
Out of Hospital Cardiac Arrest
9%
Heart Output
8%
Brain Natriuretic Peptide
8%
Nuclear Magnetic Resonance Imaging
7%
Survival Rate
6%
False Positive Result
6%
Resuscitation
6%
Confidence Interval
6%
Infection Prevention
6%